Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Yes, hematologists recommend using tocilizumab to manage cytokine release syndrome (CRS) caused by bispecific antibodies in relapsed/refractory multiple myeloma, including…
Yes, Revlimid (lenalidomide) is FDA-approved as maintenance therapy after autologous stem cell transplant for multiple myeloma.
Yes, research suggests obstructive sleep apnea (OSA) is linked to a higher risk of sarcopenia, with meta-analyses showing about 85% increased odds, though the exact mechanisms…
Yes, Pomalyst is FDA-approved for both multiple myeloma and Kaposi sarcoma, including AIDS-related and HIV-negative cases.
Yes, Xpovio (selinexor) in combination with dexamethasone alone is FDA-approved for heavily pretreated relapsed/refractory multiple myeloma after at least four prior therapies.
The case report used a combination of ixazomib, lisaftoclax, and dexamethasone (ILD) as maintenance therapy after CAR-T cell therapy for ultra-high-risk relapsed multiple myeloma.
Yes, natural products like lactacystin, salinosporamide A, and polyphenols can target the proteasome, but none are approved treatments for multiple myeloma; marizomib, a natural…
Yes, enteral nutrition therapy can help achieve remission in Chinese IBD patients, with a 60% clinical remission rate over 6 weeks, especially in Crohn's disease.
People with Crohn's disease have significantly lower oral microbial diversity compared to healthy individuals, with specific bacterial shifts and reduced butyrate metabolism.
Childhood antibiotic use is linked to a higher risk of developing inflammatory bowel disease, with a meta-analysis showing a 42% increased risk overall.
Gut microbial metabolites like short-chain fatty acids protect against colorectal cancer in IBD, while secondary bile acids, TMAO, and hydrogen sulfide promote it.
Yes, three biomarkers (ARHGEF3, S100A8, RHOU) show high diagnostic accuracy for ulcerative colitis, and bile acid ratios are also promising noninvasive markers.
Yes, the FDA-approved drug Tzield (teplizumab) delays the onset of Stage 3 type 1 diabetes in people with Stage 2 disease.
Yes, inhibiting the NF-κB pathway is a key treatment strategy for ulcerative colitis, as it reduces inflammation and may prevent cancer progression.
Ulcerative colitis patients consistently show reduced gut bacterial diversity (lower Shannon index) and altered composition compared to healthy controls, with depletion of…
Enteral nutrition therapy may help achieve remission in ulcerative colitis, with studies showing clinical remission rates around 60% and benefits in acute severe cases, but…
Yes, semaglutide can reduce total daily insulin dose in adults with type 1 diabetes and overweight or obesity, based on clinical trial and real-world data.
Wholegrain rye diets do not lead to significantly more weight loss than refined wheat diets in overweight adults, but they improve metabolic markers like inflammation and gut…
For ischemic stroke with swallowing trouble, intermittent oro-esophageal tube feeding (IOE) may be better than nasogastric tube feeding (NG) for improving nutrition, swallowing…
No, extending sleep by about 1 hour per night for 6 weeks did not change insulin sensitivity in people with overweight or obesity who were short sleepers.
Tirzepatide leads to greater weight loss than semaglutide in adults without diabetes, based on network meta-analyses and cohort studies.
Yes, stand-alone digital lifestyle interventions (fully automated apps or websites) lead to modest weight loss and improved dietary habits in adults with overweight or obesity…
Yes, women have lower 5-year survival after ischemic stroke with atrial fibrillation, but recurrence rates do not differ significantly between sexes.
Yes, higher levels of TNF pathway proteins are linked to an increased risk of recurrent ischemic stroke, according to a large meta-analysis.
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.